Iovance Biotherapeutics AAQS 2024

Iovance Biotherapeutics AAQS

Iovance Biotherapeutics Dividend yield

Ticker

IOVA

ISIN

US4622601007

WKN

A2DT49

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Iovance Biotherapeutics has a current AAQS of 5.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Iovance Biotherapeutics in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

Iovance Biotherapeutics Aktienanalyse

What does Iovance Biotherapeutics do?

Iovance Biotherapeutics Inc is a US biotechnology company specializing in the development of personalized immunotherapies for cancer patients. The company was founded in 2007 by Dr. Dendy Engelman and is headquartered in San Carlos, California. Iovance Biotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Frequently Asked Questions about Iovance Biotherapeutics Stock

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Iovance Biotherapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Iovance Biotherapeutics

Our stock analysis for Iovance Biotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Iovance Biotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.